Geriatric Nursing
Volume 24, Issue 1 , Pages 64-65 , January 2003

Steps taken toward improving dementia treatment during 2002

References 

  1. Drachman DA. The treatment of Alzheimer's disease: where have we been, and where are we going?. Am J Alzheimers Dis Other Demen. 2002;17(3):133–134
  2. Fassbender K, Stroick M, Bertsch T, Ragoschke S, Kuehl S, Walter S, et al.  Effects of statins on human cerebral cholesterol metabolism and secretion of Alzheimer amyloid peptide. Neurology. 2002;59:1257–1258
  3. Inglis F. The tolerability and safety of cholinesterase inhibitors in the treatment of dementia. Int J Clin Pract Suppl. 2002;127:45–63
  4. Rosler M. The efficacy of cholinesterase inhibitors in treating the behavioral symptoms of dementia. Int J Clin Pract Suppl. 2002;127:20–36
  5. Wesnes KA. Effects of rivastigmine on cognitive function in dementia with Lewy bodies. Dement Geriatr Cogn Disord. 2002;13(3):183–192
  6. Farlow MR. Do cholinesterase inhibitors slow progression of Alzheimer's disease?. Int J Clin Pract Suppl. 2002;127:37–44
  7. Erkinjuntii T. Treatment options: the latest evidence with galantamine (Reminyl). Neurol Sci. 2002;203–204(C) 125-30
  8. Roman GC. Vascular dementia revisited: diagnosis, pathogenesis, treatment, and prevention. Med Clin North Am. 2002;86:477–499
  9. Zandi PP, Anthony JC, Hayden KM, Mehta K, Mayer L, Breitner JCS, et al.  Reduced incidence of AD with NSAID but not H2 receptor antagonists. Neurology. 2002;59:880–886
  10. Hajjar I, Schumpert J, Dirth V, Hirth V, Wieland D, Elazer GP, et al.  The impact of the use of statins on the prevalence of dementia and the progression of cognitive impairment. J Ger Med Sci. 2002;57A:M414–M418
  11. Lopez-Arrieta JM. Nimodipine for primary degenerative, mixed and vascular dementia. Cochrane Database Systems Review. 2002;3:CD000147
  12. Panisset M. Cerebrolysin in Alzheimer's disease: a randomized, double-blind, placebo-controlled trial with a neurotrophic agent. J Neural Transm. 2002;109:1089–1104
  13. Orgogozo JM. Efficacy and safety of memantine in patients with mild to moderate vascular dementia. Stroke. 2002;33:1834–1839
  14. Kyomen HH. Estrogen therapy and noncognitive psychiatric signs and symptoms in elderly patients with dementia. Am J Psychiatry. 2002;169:1225–1227
  15. Cardinali DP. The use of melatonin in Alzheimer's disease. Neuroendocrinol Lett. 2002;23(Suppl 1):20–23

PII: S0197-4572(03)50002-7

doi: 10.1067/mgn.2003.1

Geriatric Nursing
Volume 24, Issue 1 , Pages 64-65 , January 2003

Article Tools